George Soule Five Generations, Bering Sea Gold Kelly Family Death, Articles P

BioSpace's List Of The Top 5 Biggest VC Vampires In Biotech Joel is currently a Venture Partner at RA Ventures focusing on new company creation. Eric previously served as Director, Chief Risk and Compliance Officer, Americas at Aberdeen Asset Management. While at Johns Hopkins, she spent two years as a Research Intern and Teaching Assistant in the Department of Biology and the Department of Chemistry. Benjamin Hicks is a Venture Operations Associate at RA Capital Management. Alex Martinez-Forte is an Analyst, Strategic Finance at RA Capital Management. Jake works on both public and private investments and serves as a Board Director for Xenikos, B.V, Tyra Biosciences, AavantiBio, and DiCE Molecules. Ramin is an experienced clinical trialist and previously led global clinical development programs at Akebia Therapeutics and Gilead Sciences. By continuing, you accept the use of these cookies. 4. Prior to RA, Rob spent 21 years at the Broad Institute of MIT and Harvard, most recently as the Senior Director of Technology Development and a Principal Investigator. Gabe Fox is an Associate with the TechAtlas division of RA Capital Management. Her graduate research investigated inhibitors of influenza virus and characterizing hydrophobic polycationic antimicrobial surfaces. Tom has a BS in Physiological Sciences from University of California Los Angeles. Prior to RA, Christy was a Senior Scientist in Oncology Target Discovery at Pfizer. Sonia has a BA in Chemistry and a PhD in Bioengineering, both from the University of Pennsylvania. Peter Kolchinsky @PeterKolchinsky 2h So competition among vaccine innovators required collaboration to expand production and rewards were high enough to hire all capable people in the world to work on this. He is a respected biotech leader with over twenty years of biopharma experience across global organizations. Before entering the life science space, Kat held various accounting roles in the retail industry and started her career at Ernst & Young.